{"id":"https://openalex.org/W4400973138","doi":"https://doi.org/10.5731/pdajpst.2023.012912","title":"A Strategic Guide to Improve and De-Risk Vaccine Development: CEPI\u2019s CMC Framework","display_name":"A Strategic Guide to Improve and De-Risk Vaccine Development: CEPI\u2019s CMC Framework","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4400973138","doi":"https://doi.org/10.5731/pdajpst.2023.012912","pmid":"https://pubmed.ncbi.nlm.nih.gov/39054065"},"language":"en","primary_location":{"id":"doi:10.5731/pdajpst.2023.012912","doi":"https://doi.org/10.5731/pdajpst.2023.012912","is_oa":false,"landing_page_url":"https://doi.org/10.5731/pdajpst.2023.012912","pdf_url":null,"source":{"id":"https://openalex.org/S21493941","display_name":"PDA Journal of Pharmaceutical Science and Technology","issn_l":"1079-7440","issn":["1079-7440","1948-2124"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4360969396","host_organization_name":"Parenteral Drug Association","host_organization_lineage":["https://openalex.org/P4360969396"],"host_organization_lineage_names":["Parenteral Drug Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PDA Journal of Pharmaceutical Science and Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111001774","display_name":"Anna S\u00e4rnef\u00e4lt","orcid":"https://orcid.org/0000-0003-0421-9061","observed_orcids":["https://orcid.org/0000-0003-0421-9061"]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Anna S\u00e4rnef\u00e4lt","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway anna.sarnefalt@cepi.net"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway anna.sarnefalt@cepi.net","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072921605","display_name":"Ranna Eardley\u2010Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Ranna Eardley-Patel","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075904867","display_name":"Diletta Magini","orcid":"https://orcid.org/0000-0002-2257-9979","observed_orcids":["https://orcid.org/0000-0002-2257-9979"]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Diletta Magini","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105094017","display_name":"Vishal Sonje","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Vishal Sonje","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065368236","display_name":"Antonio Guzzi","orcid":"https://orcid.org/0009-0001-3322-7274","observed_orcids":["https://orcid.org/0009-0001-3322-7274"]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Antonio Guzzi","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035701142","display_name":"Renske Hesselink","orcid":"https://orcid.org/0000-0001-7447-4434","observed_orcids":["https://orcid.org/0000-0001-7447-4434"]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Renske Hesselink","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105080447","display_name":"Matthew Scotney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Matthew Scotney","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033952104","display_name":"Alessandro Lazdins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Alessandro Lazdins","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105080448","display_name":"Valerie Chambard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Valerie Chambard","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078838845","display_name":"Christof D. Vinnemeier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Christof Vinnemeier","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080578571","display_name":"Ingrid Kromann","orcid":"https://orcid.org/0000-0002-6244-8332","observed_orcids":["https://orcid.org/0000-0002-6244-8332"]},"institutions":[{"id":"https://openalex.org/I4210118009","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50","country_code":"NO","type":"facility","lineage":["https://openalex.org/I4210118009"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Ingrid Kromann","raw_affiliation_strings":["Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coalition for Epidemic Preparedness Innovations (CEPI), 0218 Oslo, Norway","institution_ids":["https://openalex.org/I4210118009"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210118009"],"apc_list":null,"apc_paid":null,"fwci":1.4597,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.78958191,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"78","issue":"5","first_page":"613","last_page":"623"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.23109999299049377,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.23109999299049377,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.18930000066757202,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.17739999294281006,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vaccine-development","display_name":"vaccine development","score":0.8289999961853027},{"id":"https://openalex.org/keywords/chemistry-manufacturing-and-controls","display_name":"chemistry, manufacturing and controls","score":0.7879999876022339},{"id":"https://openalex.org/keywords/cepi","display_name":"CEPI","score":0.7670000195503235},{"id":"https://openalex.org/keywords/manufacturing-processes","display_name":"production process","score":0.4790000021457672},{"id":"https://openalex.org/keywords/data-analytics","display_name":"data analytics","score":0.6039999723434448},{"id":"https://openalex.org/keywords/supply-chain","display_name":"supply chain","score":0.953000009059906},{"id":"https://openalex.org/keywords/regulatory-compliance","display_name":"regulatory compliance","score":0.9490000009536743},{"id":"https://openalex.org/keywords/vaccine-candidate","display_name":"vaccine candidate","score":0.33500000834465027},{"id":"https://openalex.org/keywords/development-risk-reduction","display_name":"development risk reduction","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C21883318","wikidata":"https://www.wikidata.org/wiki/Q2297847","display_name":"Deliverable","level":2,"score":0.7405672073364258},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.6519014835357666},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.6304980516433716},{"id":"https://openalex.org/C2777042776","wikidata":"https://www.wikidata.org/wiki/Q4583103","display_name":"Preparedness","level":2,"score":0.5941314101219177},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5334432721138},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4830230176448822},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.4736284613609314},{"id":"https://openalex.org/C105339364","wikidata":"https://www.wikidata.org/wiki/Q2297740","display_name":"Software deployment","level":2,"score":0.461570143699646},{"id":"https://openalex.org/C26517878","wikidata":"https://www.wikidata.org/wiki/Q228039","display_name":"Key (lock)","level":2,"score":0.4303801953792572},{"id":"https://openalex.org/C108713360","wikidata":"https://www.wikidata.org/wiki/Q1824206","display_name":"Supply chain","level":2,"score":0.41415658593177795},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.34276872873306274},{"id":"https://openalex.org/C201995342","wikidata":"https://www.wikidata.org/wiki/Q682496","display_name":"Systems engineering","level":1,"score":0.26701247692108154},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.214569091796875},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.13016852736473083},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D000087506","descriptor_name":"Vaccine Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D014612","descriptor_name":"Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5731/pdajpst.2023.012912","doi":"https://doi.org/10.5731/pdajpst.2023.012912","is_oa":false,"landing_page_url":"https://doi.org/10.5731/pdajpst.2023.012912","pdf_url":null,"source":{"id":"https://openalex.org/S21493941","display_name":"PDA Journal of Pharmaceutical Science and Technology","issn_l":"1079-7440","issn":["1079-7440","1948-2124"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4360969396","host_organization_name":"Parenteral Drug Association","host_organization_lineage":["https://openalex.org/P4360969396"],"host_organization_lineage_names":["Parenteral Drug Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PDA Journal of Pharmaceutical Science and Technology","raw_type":"journal-article"},{"id":"pmid:39054065","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39054065","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PDA journal of pharmaceutical science and technology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Industry, innovation and infrastructure","score":0.5378999710083008,"id":"https://metadata.un.org/sdg/9"},{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413221659","https://openalex.org/W4382138147","https://openalex.org/W4302079957","https://openalex.org/W4297341018","https://openalex.org/W2405210293","https://openalex.org/W4366975820","https://openalex.org/W4283455395","https://openalex.org/W3119237484","https://openalex.org/W4412739024","https://openalex.org/W3009316597"],"abstract_inverted_index":{"The":[0,61],"Coalition":[1],"for":[2],"Epidemic":[3],"Preparedness":[4],"Innovations":[5],"(CEPI)":[6],"has":[7],"developed":[8],"a":[9,29],"robust":[10],"CMC":[11,89],"(Chemistry,":[12],"Manufacturing,":[13],"and":[14,67,76,81,109],"Controls)":[15],"Framework":[16,26,62],"to":[17,38,55,94,103],"enhance":[18],"the":[19,40,44,51,57,85,96,111,123],"likelihood":[20],"of":[21,47,59,88,98,125],"successful":[22],"vaccine":[23,48,99],"development.":[24],"This":[25],"serves":[27],"as":[28,56],"comprehensive":[30],"guide,":[31],"aiding":[32],"developers":[33],"in":[34],"building":[35],"effective":[36],"strategies":[37],"overcome":[39],"challenges":[41],"posed":[42],"by":[43],"different":[45],"phases":[46],"development,":[49,90],"including":[50],"ones":[52],"often":[53],"referred":[54],"\"valleys":[58],"death\".":[60],"lists":[63],"stage-appropriate":[64],"deliverables,":[65],"categorized":[66],"refined,":[68],"spanning":[69],"five":[70],"key":[71],"areas:":[72],"manufacturing":[73],"process,":[74,114],"formulation":[75],"stability,":[77],"analytics,":[78],"supply":[79],"chain,":[80],"compliance.":[82],"By":[83],"emphasizing":[84],"critical":[86],"aspects":[87],"CEPI's":[91],"objective":[92],"is":[93],"expedite":[95],"progression":[97],"candidates":[100],"from":[101],"research":[102],"deployment,":[104],"reducing":[105],"delays,":[106],"mitigating":[107],"risks,":[108],"optimizing":[110],"overall":[112],"development":[113],"all":[115],"while":[116],"upholding":[117],"uncompromising":[118],"quality":[119],"standards,":[120],"ultimately":[121],"increasing":[122],"probability":[124],"success.":[126]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-26T00:00:00"}